Nu-Med Plus Inc
Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. The company develops a nitric oxide generating formulation; a hospital bedside nitric oxide delivery system; a clinical unit for use in medical clinics and rehabilitation centers; a mobile rechargeable device to deliver nitric oxide gas; and a nitric ox… Read more
Nu-Med Plus Inc (NUMD) - Total Liabilities
Latest total liabilities as of September 2025: $263.71K USD
Based on the latest financial reports, Nu-Med Plus Inc (NUMD) has total liabilities worth $263.71K USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nu-Med Plus Inc - Total Liabilities Trend (2014–2024)
This chart illustrates how Nu-Med Plus Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nu-Med Plus Inc Competitors by Total Liabilities
The table below lists competitors of Nu-Med Plus Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
TAKE-TWO INTERACT
BE:TKE
|
Germany | €7.28 Billion |
|
AS Latvijas balzams
MU:UM9
|
Germany | €55.41 Million |
|
Zwahlen et Mayr SA
SW:ZWM
|
Switzerland | CHF20.55 Million |
|
Vision Marine Technologies Inc
NASDAQ:VMAR
|
USA | $55.41 Million |
|
Nampak
JSE:NPK
|
South Africa | ZAC8.19 Billion |
|
Kuniko Ltd
AU:KNI
|
Australia | AU$2.10 Million |
|
Strategic Energy Resources Ltd
AU:SER
|
Australia | AU$712.03K |
Liability Composition Analysis (2014–2024)
This chart breaks down Nu-Med Plus Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.02 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.02 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 52.24 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nu-Med Plus Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nu-Med Plus Inc (2014–2024)
The table below shows the annual total liabilities of Nu-Med Plus Inc from 2014 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $224.47K | +40.11% |
| 2023-12-31 | $160.21K | +12.37% |
| 2022-12-31 | $142.57K | -7.73% |
| 2021-12-31 | $154.52K | +72.78% |
| 2020-12-31 | $89.43K | -78.51% |
| 2019-12-31 | $416.21K | +11.14% |
| 2018-12-31 | $374.49K | +10.64% |
| 2017-12-31 | $338.48K | -99.98% |
| 2017-09-30 | $1.67 Billion | +37169.57% |
| 2016-12-31 | $4.47 Million | -99.75% |
| 2016-09-30 | $1.79 Billion | +11600.01% |
| 2015-12-31 | $15.30 Million | -97.67% |
| 2015-09-30 | $656.31 Million | +245868.19% |
| 2014-12-31 | $266.83K | -- |